Park Medi World reported a consolidated net profit of ₹885.93 million for the quarter ended June 30, 2026, marking a 34% year-on-year increase from ₹655.06 million in Q1FY25. The growth was driven by a 19% rise in revenue from operations to ₹4,757.09 million, supported by the integration of new hospital capacities and operational efficiencies across its network of 17 hospitals and 4,290 beds.

The Board of Directors approved the financial results on August 03, 2026, pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory auditors Agiwal & Associates issued an unmodified limited review report on both standalone and consolidated statements. The company also disclosed the acquisition of Mehar Hospital-Zirakpur from Mehar Mediserve LLP for an all-cash consideration of approximately ₹1,070 million, aimed at deepening its presence in the Tricity cluster.

Financial Performance

Consolidated revenue from operations grew to ₹4,757.09 million in Q1FY27, compared to ₹3,988.45 million in the prior year period. Profit before tax stood at ₹1,050.84 million, up from ₹818.99 million. EBITDA increased by 20% to ₹1,260.88 million from ₹1,049.31 million in Q1FY25. Total comprehensive income attributable to owners of the parent was ₹819.38 million. Basic earnings per share (EPS) increased to ₹2.05 from ₹1.70 in the corresponding quarter last year.

Standalone results showed more modest growth, with net profit after tax at ₹10.84 million versus ₹48.97 million in Q1FY25. Standalone revenue from operations rose 46% YoY to ₹335.32 million from ₹229.69 million, though other income declined significantly from ₹82.69 million in Q4FY25 to ₹46.68 million in Q1FY26.

Strategic Acquisitions and Expansion

The company executed a definitive agreement to acquire 100% stake in Mehar Mediserve LLP, which operates Mehar Hospital-Zirakpur, a 150+ bed multi-super speciality facility. The transaction is valued at ₹1,070 million and is expected to be commissioned under the Park brand by November 2026. This acquisition complements existing facilities in Mohali, Panchkula, Patiala, and Bathinda, reinforcing the group’s cluster-based strategy in Punjab.

As a subsequent event, Park Medi World acquired an 80% shareholding in V3 Healthcare Private Limited on July 31, 2026, for approximately ₹1,770 million. V3 operates The Medicity Hospital-Rudrapur, a 330-bed facility in Uttarakhand, which launched on August 2, 2026. The remaining 20% stake will be acquired by April 30, 2030.

Capacity Additions and IPO Utilization

The group has added approximately 1,500 beds in the past twelve months, representing a 46% capacity expansion. Key launches include a 350-bed hospital in Panchkula (April 2026) and the upcoming expansion of Park Hospital in Palam Vihar, Gurugram, branded as "Park Hospital Platinum," adding 100 beds by November 2026 at a cost of ₹250 million funded from internal accruals. RGS Healthcare Limited’s Mohali unit is also expanding from 350 to 500 beds at a cost of ₹400 million.

Regarding IPO proceeds, ₹6,484.45 million out of ₹7,132.77 million planned for specific objects has been utilized as of June 30, 2026. The remaining ₹648.32 million is pending utilization for capital expenditure on new hospitals and medical equipment. The Board proposed a variation in the objects of IPO proceeds, subject to shareholder approval via postal ballot.

Park Medi World launched The Medicity Hospital, Rudrapur, on August 02, 2026, marking its strategic entry into the Uttarakhand market. The 330-bed multi-super specialty facility is the largest hospital in the Kumaon region and expands the group’s operational footprint to six states across North India. This launch strengthens the company’s positioning as a leading multi-state healthcare platform by adding significant bed capacity in an underserved catchment area, aiming to capture rising demand for tertiary and quaternary care.

The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company disseminated the information to BSE Limited and National Stock Exchange of India Limited, with further details available on its corporate website.

Facility Details

The new facility focuses on tertiary and quaternary care, equipped with advanced multi-disciplinary clinical capabilities. It is staffed by specialists from premier medical institutions, aiming to capture rising healthcare demand in the region. The hospital primarily serves the domestic market within India.

Strategic Expansion Context

Dr. Ankit Gupta, Managing Director of Park Medi World Limited, stated that the launch cements the group’s position as a dominant multi-super specialty healthcare platform in North India. He noted that the facility addresses accelerating demand for specialized care in the Kumaon region, which he described as underpenetrated with significant untapped demand. The expansion aligns with the group’s strategy of building centers of excellence to drive sustainable patient volumes and long-term revenue growth.

What the Numbers Show

Park Medi World currently operates 17 hospitals with a combined capacity of approximately 4,300 beds, making it North India’s second-largest hospital chain. The addition of the 330-bed Rudrapur facility contributes to a broader growth trajectory that includes integrating three additional hospitals and expanding three existing units. These ongoing projects are expected to add 1,300 beds to the network, raising the total capacity to approximately 5,600 beds by March 2028. This scale-up underscores a disciplined approach to regional density and referral synergies across its 15-city presence.